by Stacey Johnson | Nov 28, 2014
. If you’ve never heard of epidermolysis bullosa (EB), you’re not alone. This rare genetic disease, which occurs in one of 20,000 births, creates fragile skin that tears at the slightest touch and results in blisters, sores and scar tissue. There is no cure. EB...
by Mark Curtis | Nov 27, 2014
. Welcome to your Update from the Clinic for the month of October. Northwest Biotherapeutics continues to receive support for its cancer vaccine platform in Europe. Neuralstem and StemCells provided updates on their respective clinical programs for spinal cord injury....
by Holly Wobma | Nov 24, 2014
> For anyone who follows crime dramas, you’ve probably come across the token episode where the resident computer genius pulls up a double helix to unravel some genetic clue about an elusive villain. Of course, most people know that the information in DNA requires...
by David Kent | Oct 30, 2014
> One of the consistent themes of the Till and McCulloch Meetings (#TMM2014) is its commitment to having students and postdocs on stage presenting their work. These sessions have been regularly cited by my colleagues as the most interesting and engaging sessions...
by David Kent | Oct 28, 2014
> Last month, Signals re-posted a blog entry of mine from The Black Hole where I lamented the lack of teamwork in the life sciences. There are, however, always exceptions and I want to highlight one such exception that took the field of blood stem cell expansion by...
by Stacey Johnson | Oct 17, 2014
. I don’t disagree with that quote by educator and humanitarian Helen Keller, a woman who overcame her inability to see, hear and speak, and graduated from college in 1904. However, I’m extremely squeamish when it comes to eyes. Perhaps it started in grade 8 science...
Comments